Fast and sustained improvement of patient-reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting.
Chicharro P, Llamas-Velasco M, Armesto S, Herrera-Acosta E, Vidal D, Vilarrasa E, Rivera R, De la Cueva P, Martorell-Calatayud A, Ballescà F, Belinchón I, Carretero G, Rodríguez L, Romero-Maté A, Pujol-Montcusí J, Salgado L, Sahuquillo-Torralba A, Coto-Segura P, Baniandrés-Rodríguez O, Feltes R, Alsina M, Daudén E.
Chicharro P, et al. Among authors: coto segura p.
Dermatol Ther. 2022 Aug;35(8):e15653. doi: 10.1111/dth.15653. Epub 2022 Jun 29.
Dermatol Ther. 2022.
PMID: 35731640